Use of ribaxamase (SYN-004), a β-lactamase, to prevent Clostridium difficile infection in β-lactam-treated patients: a double-blind, phase 2b, randomised placebo-controlled trial
Titel:
Use of ribaxamase (SYN-004), a β-lactamase, to prevent Clostridium difficile infection in β-lactam-treated patients: a double-blind, phase 2b, randomised placebo-controlled trial
Auteur:
Kokai-Kun, John F Roberts, Tracey Coughlin, Olivia Le, Chenxiong Whalen, Heidi Stevenson, Ralph Wacher, Vincent J Sliman, Joseph